Search Results for "global" | Oncology Voice Network

B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Apr 20^th • 8 mins read

Shani Paluch-Shimon, Nathan I. Cherny, Elisabeth G.E. de Vries, Urania Dafni, Martine J. Piccart, Nicola Jane Latino, Fatima Cardoso

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Sep 6^th • 20 mins read

Idine Mousavi, BA; Timothée Olivier, MD; Vinay Prasad, MD, MPH

Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022

Jun 10^th • 30 mins read

Natansh D. Modi, BPharm; Ahmad Y. Abuhelwa, PhD; Ross A. McKinnon, PhD

Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration

Jul 28^th • 20 mins read

Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Aug 2^nd • 3 mins read

Rajat Thawani, Neha Agrawal, Nicholas F Taflin, Adel Kardosh, Emerson Y Chen

Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer

Jan 13^th • 8 mins read

Kristina Jenei, BSN, MS, Daniel E. Meyers, MD, MS, Vinay Prasad, MD, MPH

The Inclusion of Women in Global Oncology Drug Trials Over the Past 20 Years

Aug 26^th • 2 mins read

Chad Williamson, MBA, MS Leanne Berger, BS, Thomas P. Sullivan, BS SHOW

Addressing oncologists' gaps in the use of biosimilar products

Jun 19^th • 5 mins read

Jonathan H Seltzer MD, MBA, MA, Gary Gintant PhD, Laleh Amiri-Kordestani MD, Jack Singer MD, Luana Pesco Koplowitz MD, PhD, Javid J Moslehi MD, Ana Barac MD, PhD, Anthony F. Yu MD

Assessing cardiac safety in oncology drug development

Jun 12^th • 12 mins read

M. Bertagnolli and J. Tabernero

Value assessment frameworks in oncology: championing concordance through shared standards

Feb 18^th • 1 min read